State Of Wisconsin Investment Board Vertex Pharmaceuticals Inc Transaction History

State Of Wisconsin Investment Board

$36.2 Billion
Q2 2024

A detailed history of State Of Wisconsin Investment Board transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 149,254 shares of VRTX stock, worth $75 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

149,254

Previous 161,962 7.85%

Holding current value

$75 Million

Previous $67.7 Million 3.33%

% of portfolio

0.19%

Previous 0.19%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $4.99 Million - $6.17 Million	-12,708 Reduced 7.85%	149,254 $70 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $1.62 Million - $1.77 Million	3,974 Added 2.52%	161,962 $67.7 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $563,549 - $674,747	-1,643 Reduced 1.03%	157,988 $64.3 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $7.01 Million - $7.51 Million	-20,728 Reduced 11.49%	159,631 $55.5 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $3.26 Million - $3.65 Million	10,377 Added 6.1%	180,359 $63.5 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $430,509 - $491,112	-1,520 Reduced 0.89%	169,982 $53.6 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $2.17 Million - $2.44 Million	-7,591 Reduced 4.24%	171,502 $49.5 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $11.5 Million - $12.8 Million	-41,856 Reduced 18.94%	179,093 $51.9 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $7.01 Million - $8.73 Million	-29,829 Reduced 11.89%	220,949 $62.3 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $9.74 Million - $11.5 Million	43,978 Added 21.27%	250,778 $65.4 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $11 Million - $13.9 Million	-62,201 Reduced 23.12%	206,800 $45.4 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $28.3 Million - $31.6 Million	-155,828 Reduced 36.68%	269,001 $48.8 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $25.9 Million - $30.5 Million	137,996 Added 48.11%	424,829 $85.7 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $13.8 Million - $16.1 Million	-66,713 Reduced 18.87%	286,833 $61.6 Million
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $568,449 - $758,143	2,746 Added 0.78%	353,546 $83.6 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $2.12 Million - $2.51 Million	-8,291 Reduced 2.31%	350,800 $95.5 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $33.8 Million - $44.3 Million	149,809 Added 71.58%	359,091 $104 Million
Q1 2020 May 06, 2020	SELL	$199.77 - $247.81 $7.38 Million - $9.16 Million	-36,963 Reduced 15.01%	209,282 $49.8 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $2.69 Million - $3.61 Million	-16,118 Reduced 6.14%	246,245 $53.9 Million
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $13.8 Million - $15.5 Million	-82,941 Reduced 24.02%	262,363 $44.5 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $4.72 Million - $5.46 Million	-28,701 Reduced 7.67%	345,304 $63.3 Million
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $7.82 Million - $9.3 Million	47,755 Added 14.64%	374,005 $68.8 Million
Q4 2018 Feb 11, 2019	BUY	$151.91 - $192.21 $3.6 Million - $4.55 Million	23,680 Added 7.83%	326,250 $54.1 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $1.95 Million - $2.24 Million	-11,629 Reduced 3.7%	302,570 $58.3 Million
Q2 2018 Aug 03, 2018	BUY	$145.72 - $169.96 $7.43 Million - $8.67 Million	50,990 Added 19.37%	314,199 $53.4 Million
Q1 2018 May 07, 2018	SELL	$151.6 - $177.13 $2.15 Million - $2.51 Million	-14,161 Reduced 5.11%	263,209 $42.9 Million
Q4 2017 Feb 08, 2018	BUY	$137.28 - $155.55 $7.82 Million - $8.86 Million	56,936 Added 25.83%	277,370 $41.6 Million
Q3 2017 Nov 01, 2017	BUY	$148.13 - $162.24 $32.7 Million - $35.8 Million	220,434	220,434 $33.5 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Vertex Pharmaceuticals Inc Transaction History